| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5208100
Max Phase: Preclinical
Molecular Formula: C21H36N2O2
Molecular Weight: 348.53
Associated Items:
Representations
Canonical SMILES: CC(C1CCCCC1)N1C[C@H](O)C[C@]12CCN(C1CCCCC1)C2=O
Standard InChI: InChI=1S/C21H36N2O2/c1-16(17-8-4-2-5-9-17)23-15-19(24)14-21(23)12-13-22(20(21)25)18-10-6-3-7-11-18/h16-19,24H,2-15H2,1H3/t16?,19-,21+/m1/s1
Standard InChI Key: UTQZVHDRJRCOJG-MDFYDDKXSA-N
Associated Targets(Human)
11-beta-hydroxysteroid dehydrogenase 1 5910 Activities
HERG 29587 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Pregnane X receptor 6667 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Nuclear receptor subfamily 1 group I member 2 641 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 348.53 | Molecular Weight (Monoisotopic): 348.2777 | AlogP: 3.33 | #Rotatable Bonds: 3 |
| Polar Surface Area: 43.78 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.18 | CX LogP: 3.07 | CX LogD: 1.29 |
| Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.85 | Np Likeness Score: 0.17 |
References
| 1. Burns DM, He C, Li YL, Zhuo J, Qian DQ, Chen L, Jalluri R, Diamond S, Covington MB, Li Y, Wynn R, Scherle P, Yeleswaram S, Hollis G, Friedman S, Metcalf B, Yao W.. (2022) Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1., 73 [PMID:35835377] [10.1016/j.bmcl.2022.128884] |
Source
Source(1):